---
document_datetime: 2023-09-21 20:54:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/noxafil-epar-all-authorised-presentations_en.pdf
document_name: noxafil-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0267266
conversion_datetime: 2025-12-27 22:26:43.886142
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                                     | Route of Administration   | Immediate Packaging                                    | Content (concentration)       | Pack size                                                                                                                                                          |
|------------------|-------------------|------------|---------------------------------------------------------|---------------------------|--------------------------------------------------------|-------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| EU/1/05/320/001  | Noxafil           | 40 mg/ml   | Oral suspension                                         | Oral use                  | bottle (glass)                                         | 105 ml                        | 1 bottle                                                                                                                                                           |
| EU/1/05/320/002  | Noxafil           | 100 mg     | Gastro-resistant tablet                                 | Oral use                  | blister (PVC/aclar/alu)                                |                               | 24 tablets                                                                                                                                                         |
| EU/1/05/320/003  | Noxafil           | 100 mg     | Gastro-resistant tablet                                 | Oral use                  | blister (PVC/aclar/alu)                                |                               | 96 tablets                                                                                                                                                         |
| EU/1/05/320/004  | Noxafil           | 300 mg     | Concentrate for solution for infusion                   | Intravenous use           | vial (glass)                                           | 16.7 ml                       | 1 vial                                                                                                                                                             |
| EU/1/05/320/005  | Noxafil           | 300 mg     | Gastro-resistant powder and solvent for oral suspension | Oral use                  | powder: sachet (PET/alu/LLDPE); solvent: bottle (HDPE) | powder: 300 mg; solvent: 9 ml | Box 1: 8 sachets + 2 syringes of 3 ml + 2 syringes of 10 ml + 2 mixing cups + 1 solvent bottle + 1 bottle adapter; Box 2: 6 syringes of 3 ml + 6 syringes of 10 ml |